MC1R and melanoma: We found that one of the peptides, namely 67Cu-NOTA-PEG2Nle-CycMSHhex, exhibited favorable melanoma targeting and biodistribution properties that underscored its potential as an MC1R-targeted therapeutic peptide for melanoma treatment in the future.